<unk>  is well absorbed orally. The onset of action is usually within 48 hours when used for parkinsonian syndromes, including dyskinesia. As plasma concentrations of<unk>  increase, there is a greater risk for toxicity. Half-life elimination averages eight days in patients with end-stage kidney disease.<unk>  is only minimally removed by hemodialysis.<unk>  is metabolized to a small extent (5-15%) by acetylation. It is mainly excreted (90%) unchanged in urine by kidney excretion.
Amantadine
Rimantadine
Quifenadine
Alcaftadine
Umifenovir
Tecovirimat
Rupatadine
Inadine